Table 2.
Salient features of Indian pediatric patients with the Lane-Hamilton syndrome
| Author (year of publication) | Age and sex | Clinical presentation | Diagnostic investigation | Treatment | Outcome |
|---|---|---|---|---|---|
| Agarwal S et al. (2018)[22] | 14 years/M | Cough, intermittent hemoptysis, progressive pallor | Sputum examination | GFD | Survived |
| Panda PK et al. (2017)[15] | 16 years/M | Steatorrhea, stunted growth, cough, episodic hemoptysis with breathlessness | Bronchoalveolar lavage and transbronchial lung biopsy | GFD | Survived |
| Sethi GR et al. (2011)[23] | 7 years/F | Episodic respiratory distress since infancy, hemoptysis | Bronchoalveolar lavage | GFD, inhaled corticosteroids | Survived |
| 14 years/M | Pallor, malaise, dyspnea on exertion, congestive cardiac failure, hemoptysis | Bronchoalveolar lavage | GFD, oral corticosteroids, azathioprine (prior to starting GFD) | Survived | |
| 11 years/M | Pallor, malaise, increasing fatiguability | Bronchoalveolar lavage | GFD, inhaled corticosteroids | Survived | |
| Narula N et al. (2010)[24] | 13 years/M | Recurrent hemoptysis, dyspnea on exertion, stunted growth, pallor, dilated cardiomyopathy | Bronchoalveolar lavage | GFD, diuretics, enalapril, digoxin | Survived |
M=Male; F=Female; GFD=gluten-free diet